April 29, 2020
JCRI-ABTS to treat Cov-19 patients with HERO
JCRI said Wednesday it is seeking approval from the Food and Drug Administration (FDA) under its Emergency Use Authorization (EUA) for using the Canady Helios Cold Plasma HERO (Humidified Electrical Reactive Oxygen) System for the treatment of patients infected with COVID-19 virus.